Efficacy and safety of 1,000 mg effervescent aspirin: Individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms

Journal of Neurology

Volumn 254, Issue 6, 2007, Pages 705-712

  Lampl, Christian ^a   Voelker, M ^b   Diener, H C ^c  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Effervescent aspirin; Migraine; Sumatriptan

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; SUMATRIPTAN;

ADULT; ADVERSE OUTCOME; ANALGESIA; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EFFERVESCENT TABLET; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REMISSION; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAUSEA; PAIN MEASUREMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN AGONISTS; SUMATRIPTAN; TIME FACTORS; TREATMENT OUTCOME; VOMITING;

EID: 34347334536     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0547-2     Document Type: Article

References (26)

1. Rasmussen BK (1995) Epidemiology of headache. Cephalalgia 15:45-68
2. WHO (2001) The World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva
3. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationship to age, gender and ethnicity. Cephalalgia 23:519-527
4. Pfaffenrath V, Scherzer S (1995) Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia Suppl 15:14-20
5. 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. The Lancet 358:1668-1675
6. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine - current understanding and treatment. N Engl J Med 346:257-270
7. Oldman AD, Smith LA, McQuay HJ, Moore RA (2002) Pharmacological treatments for acute migraine: quantitative systematic review. Pain 97:247-257
8. 1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633-658
9. Lipton RB, Bigal ME, Goadsby PJ (2004) Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia 24:321-332
10. Limmroth V, Katsarava Z, Diener HC (1999) Acetylsalicylic acid in the treatment of headache. Cephalalgia 19:545-551
11. Diener HC, Lampl C, Reimnitz P, Voelker M (2006) Aspirin in the treatment of acute migraine attacks. Expert Rev.Neurotherapeutics 6:563-573
12. Lange R, Schwarz JA, Hohn M (2000) Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebocontrolled parallel group study. Cephalalgia 20:663-667
13. Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Gobel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller- Schwefe G, Nappi G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M; EMSASI Study Group (2004) Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24:947-954
14. Diener HC, Eikermann A, Gessner U, Gobel H, Haag G, Lange R, May A, Müller-Schwefe G, Voelker M (2004) Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 52:50-56
15. Chalmers I (1993) The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health. Annals of the New York Academy of Science 703:156-165
16. Steinberg KH, Smith SJ, Stroup DF, Olkin I, Lee NC, Williamson GD, Thacker SB (1997) Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. Am J Epidemiol 145:917-925
17. Smith CT, Williamson PR, Marson AG (2005) An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. Journal of Evaluation in Clinical Practice 11:468-478
18. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7):1-93
19. Diener HC, Ferrari M, Mansbach H for the SNAP Database Study Group (2004) Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Neurology 63:520-524
20. Fox AW, Davis RL (1998) Migraine chronobiology. Headache 38:436-441
21. Silberstein SD, Edlund W (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence- based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754-762
22. Fox AW, Keywood C, Sheftell FD, Spierings EL, Winner P (2002) Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT1B/1D agonist efficacy in migraine. Headache 42:680-688
23. MacGregor EA, Dowson A, Davies PT (2002) Mouth-dispersible aspirin in the treatment of migraine: a placebocontrolled study. Headache 42:249-255
24. Mullins CD, Weis KA, Perfetto EM, Subedi PR, Healey PJ (2005) Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. J Manag Care Pharm 5:394-402
25. McCrory DC, Gray RN (2003) Oral sumatriptan for acute migraine. Cochrane Database of Systematic Reviews, Issue 3. Art.No.: CD002915
26. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 22:1035-1048